Combined chemotherapy with 5-FU and BCNU was compared with placebo in a triple-blind, randomized study of 40 patients with pancreatic adenocarcinoma. There were no significant differences between the groups with regard to survival, tumor size, or quality of life.
No takes yet. Share an insight, caveat, or question.
Andersen et al. (1981) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: